Many environmental, host, and microbial characteristics have been recognized as risk factors for dissemination of extrapulmonary tuberculosis (EPTB). However, there are few population-based studies investigating the association between the primary sites of tuberculosis (TB) infection and mortality during TB treatment. De-identified populationbased surveillance data of confirmed TB patients reported from 2009 to 2015 in Texas, USA, were analyzed. Regression analyses were used to determine the risk factors for EPTB, as well as its subsite distribution and mortality. We analyzed 7007 patients with exclusively pulmonary TB, 1259 patients with exclusively EPTB, and 894 EPTB patients with reported concomitant pulmonary involvement. Age ≥45 years, female gender, human immunodeficiency virus (HIV)-positive status, and end-stage renal disease (ESRD) were associated with EPTB. ESRD was associated with the most clinical presentations of EPTB other than meningeal and genitourinary TB. Patients age ≥45 years had a disproportionately high rate of bone TB, while foreign-born patients had increased pleural TB and HIV+ patients had increased meningeal TB. Age ≥45 years, HIV+ status, excessive alcohol use within the past 12 months, ESRD, and abnormal chest radiographs were independent risk factors for EPTB mortality during TB treatment. The epidemiologic risk factors identified by multivariate analyses provide new information that may be useful to health professionals in managing patients with EPTB.
Introduction
Tuberculosis (TB), especially with human immunodeficiency virus (HIV) co-infection, is a leading cause of death worldwide 1 . Individuals infected with Mycobacterium tuberculosis (Mtb) may either be asymptomatic (latent TB infection, LTBI) or develop active TB disease 2 . For active TB disease, a small subset of patients (19.3-39 .3%) present with either primary extrapulmonary tuberculosis (EPTB) or EPTB concurrent with pulmonary involvement, while the majority of patients develop pulmonary TB (PTB) 3, 4 . Some studies have suggested that the proportion of EPTB among all TB cases has been increasing in the United States (USA) (21% in 2013 compared to 16% in 1993) mainly because of the increasing prevalence of HIV infection 5, 6 . Typically, Mtb infection leads to spatial and temporal lesion dynamics not only within a single individual but also between individuals 7, 8 . The most common extrapulmonary sites of TB infection are the lymph nodes, the pleura, the genitourinary system, the gastrointestinal tract, the bones, and the central nervous system. To date, the mechanisms for extrapulmonary dissemination remain largely unknown 2 . It has been found that host-pathogen interactions such as pathogen-associated molecular pattern signaling, antigen presentation, and immune recognition may be used by Mtb to mediate latency induction and pathogen reactivation 2 . These factors are believed to be important in establishing the site of disease presentation and dissemination. One recent study, which assessed within-host bacterial population dynamics in a macaque TB model by using a genome barcoding system coupled with serial 18 F-fluorodeoxyglucose radiotracers and positron emission tomography co-registered with computed tomography (PET/CT), suggested that in the first 6 weeks after infection, granuloma size but not bacterial burden is correlated with risk of local dissemination (<10 mm away) in the lungs 9 . Furthermore, genomic analyses of samples from lung and extrapulmonary biopsies of HIV-co-infected patients have demonstrated that the dissemination of Mtb from the lungs to extrapulmonary sites may occur as frequently as between lung sites 10 . Importantly, Mtb sublineages were differentially distributed throughout the lungs of these immunocompromised patients. Therefore, data from Lieberman and co-workers 10 suggest that biopsies from the upper airway represent only a small fraction of the population diversity. These data are also consistent with a nonhuman-primate-model study which showed barcodes recovered from gastric and bronchoalveolar lavage samples represented only a fraction (3.75%) of all bacterial barcodes 9 . Additionally, there has been a study evaluating the immune response profile of inflammatory cytokines such as interferon-γ, interleukin (IL)-1β, and tumor necrosis factor (TNF)-β in HIV-negative children with TB disease 11 . At the time of TB diagnosis, the immune response in all pediatric TB patients (suppressed proinflammatory cytokines and increased regulatory T cell frequency) was not significantly different between PTB and EPTB patients. However, the recovery of the immune response was observed in children with PTB but not in children with EPTB after 6 months of TB treatment 11 . These findings suggest that the host immune response following treatment is specific to the disease (PTB vs. EPTB) rather than due to the within-host defense and cannot explain why one individual develops PTB while another develops EPTB.
Clinically, EPTB is still underrecognized, and diagnoses are often delayed due to its paucibacillary nature and atypical presentations. In fact, many characteristics such as HIV and female gender have been recognized as risk factors for EPTB dissemination [12] [13] [14] . However, there are few population-based studies in the USA investigating the association between primary sites of Mtb infection and mortality during TB treatment. For instance, one study analyzed the epidemiology and risk factors of EPTB from 1993 through 2006 but did not analyze risk factors for patient mortality 5 . Another study demonstrated risk factors for EPTB and mortality at 6 months after TB diagnosis from 1995 through 1999 in Harris Country, Texas, but this study analyzed data at the county level and not at the state or country level 15 . The third example is the association of Mtb lineage with the site of TB disease in a study that analyzed US data from 2004 through 2008; the study reported that the Euro-American, Indo-Oceanic, and East African-Indian bacterial lineages were found exclusively in EPTB 12 . Given the variety of organ-specific clinical scenarios and the nonspecific systemic symptoms of EPTB, a more profound understanding of the site distribution of EPTB, as well as the risk factors associated with extrapulmonary dissemination and mortality, is important for developing suitable protocols to manage EPTB patients. Accordingly, this analysis aimed to determine the characteristics associated with EPTB dissemination and mortality during TB treatment by using recent epidemiological data from Texas.
Materials and methods
De-identified surveillance data of all confirmed TB patients reported to the Centers for Disease Control and Prevention's TB Genotyping Information Management System (TBGMIS) between January 2009 and December 2015 from the state of Texas, USA, were analyzed. TB disease was classified as exclusively PTB, exclusively EPTB or EPTB with concurrent PTB involvement. Sites of EPTB include pleural, lymphatic, bone, genitourinary, peritoneal, and meningeal locations, among others. All patients received anti-TB treatment, and their outcomes were recorded as "completed", "died", or "unknown".
Cases were categorized by site of disease. Differences across groups (exclusively PTB, exclusively EPTB and EPTB with concurrent PTB involvement) were determined by the chi-squared test or Fisher's exact test as appropriate. Logistic regression was used to determine the characteristics that were associated with patients having exclusively PTB compared to individuals identified to have (1) exclusively EPTB, (2) EPTB with concurrent PTB involvement, or (3) any EPTB (patients with exclusively EPTB and EPTB with concurrent PTB involvement). Odds ratios (OR), adjusted odds ratios ( a OR), and 95% confidence intervals (CI) were reported. Multiple logistic regression modeling was also used to determine the risk of patient mortality during treatment in patients with exclusively EPTB. Analyses were performed with SPSS 16.0 (SPSS, Inc., Chicago, Illinois, USA) and Stata MP14.2 (StataCorp LP, College Station, TX, USA). A p-value of <0.05 was considered statistically significant.
Results

Study population and characteristics
From 2009 to 2015, there were 9246 confirmed TB patients in Texas recorded in the TBGIMS database. After excluding 86 patients because their EPTB site was unknown, we included 9160 TB patients in the analysis (Fig. 1) . The patients' demographic and clinical characteristics are presented in Table 1 . The majority of exclusively EPTB patients were male (55.4%) and foreign born (59.1%). The proportions of patients age 25-44 years (39.6%) and Hispanic patients (46.6%) with exclusively EPTB were higher than the proportions of other age or ethnic groups with exclusively EPTB. The percentage of TB contact history was higher in patients with exclusively EPTB (3.7%) than in patients with PTB (9.0%) or EPTB with concurrent PTB (6.9%). In patients with exclusively EPTB, 448/1259 (35.6%) had abnormal chest radiographs and 17/1259 (1.4%) had culture-positive specimens. Multidrug-resistant TB (MDR-TB) was identified in 0.4% of exclusively EPTB cases, 0.1% of EPTB cases with concurrent PTB, and 0.8% of exclusive PTB cases. Two extensively drug-resistant cases were identified in PTB patients. The most prevalent Mtb lineages of exclusively EPTB were Euro-American L4, East Asian L2, and IndoOceanic L1.
Sites of EPTB
The distribution of EPTB sites is shown in Fig. 2a . Of the patients with exclusively EPTB, the most common sites of TB disease included pleural (15.7%), lymphatic (32.3%), bone (12.2%), and meningeal (7.5%) sites. The most common sites of TB disease in patients having EPTB with concomitant PTB were also pleural (38.1%), lymphatic (20.8%), bone (7.9%), and meningeal (6.7%) areas. Risk factors for mortality during treatment in patients with exclusively EPTB Among the 1111 patients with exclusively EPTB who had mortality-related data available, 50 (4.5%) died during anti-TB treatment. Mortality was highest among those patients presenting with meningeal (9.6%) or peritoneal TB (8.5%) and lower among those individuals with lymphatic TB (0.7%) (Fig. 2b) 
Risk factors for EPTB and its specific sites
Discussion
Although risk factors for the development of exclusively EPTB compared to PTB have been described in several studies 5, 12, 16, 17 , there are still inconsistent findings among studies from different regions, including substantial state-level heterogeneity in the reported epidemiological data 18 . We performed an analysis of EPTB patients in the state of Texas. We found that patients who were age ≥45 years, female, HIV+, and suffering from ESRD were at a significantly elevated risk of EPTB. In particular, age ≥45 years, HIV+, excessive alcohol use 
within the past 12 months, ESRD, and abnormal chest radiographs were risk factors for EPTB mortality during treatment.
The observed demographics of female gender and foreign-born origin in the USA have been previously reported as risk factors for EPTB 5, 12, 17, 19, 20 . Similarly, we found that female gender and Hispanic ethnicity were associated with patients who presented with exclusively EPTB after adjusting for other confounding factors. We further noted that ethnicity was not associated with any specific site of EPTB and that female gender was associated with lymphatic and peritoneal TB.
The risk of TB development in the foreign-born population was substantially elevated even more than 5 years after entering the USA 20 . In our study population, more than half (55.2%) of the patients were born outside the USA. The cervical lymphatic site was found to be a more common disease site among foreign-born EPTB patients than among US-born patients in North Carolina 21 . However, a study at a single urban US public hospital did not show any risk between foreign birth with sites of EPTB 13 . From our results, foreign birth was associated with increased risk of pleural TB. Pleural TB is the second most common type of EPTB but the leading manifestation in settings with high TB 22, 23 . Given that TB disease among foreign-born populations is normally considered to result from the reactivation of LTBI 24 , one explanation might be that pleural TB was the primary manifestation of LTBI reactivation 22 . It is also possible that the association between foreign birth and pleural TB is due to the effect of BCG vaccination on foreign-born individuals. Studies have shown that pleuritis is induced by Mycobacterium bovis BCG, and the underlying mechanisms have been elucidated 25 . However, non-association of BCG status among patients with PTB, pleural TB, and other types of EPTB was seen in a study with a majority of BCG-vaccinated patients 23 . From the findings described herein, studies can be initiated to further evaluate the BCG status of foreignborn patients in relation to pleural TB. Drug users and the elderly remain the groups at high risk of developing LTBI and TB disease 19 . The prevalence of illicit drug use has been previously shown to be higher in patients with PTB than in patients with EPTB 15, 17 . Similarly, the prevalence of injecting drug use and non-injecting drug use was also higher in patients with PTB than patients with exclusively EPTB in our study. We further observed that injecting drug use was associated with patients with genitourinary TB. In addition, non-injecting drug use as a non-risk factor for EPTB compared to PTB has been reported 26 . From our results, non-injecting drug use was also negatively associated with patients having exclusively EPTB or any EPTB compared to PTB. We demonstrated that the age groups 15-24 and 45-64 were associated with exclusively EPTB. Meanwhile, Click et al. 12 indicated that age 0-4 was associated with exclusively EPTB. TB in elderly patients can involve almost any organ in the body 27 . We found that patients age >45 years were at an increased risk of bone TB but not with other extrapulmonary sites. This finding is consistent with a large-population-based study in Europe 16 . Additionally, ages <15 and >65 years were likely to be associated with the most comment types of EPTB 15 . According to a 2016 CDC report, high rates of TB cases overall and TB cases attributable to extensive recent transmission were identified frequently among people experiencing homelessness within the past year and residents of a correctional facility at the time of diagnosis 28 . However, EPTB was more common in non-homeless patients than in the homeless, as previously reported 5, 17 . The number of homeless cases was significantly higher in PTB (5.8%) than in exclusively EPTB (2.4%) in our population. Furthermore, we showed that being homeless was negatively associated with EPTB and especially lymphatic TB. Neither the Magee study nor our study showed any significant differences in the proportion of residents of correctional facility patients with exclusively EPTB vs. PTB 17 . These findings suggest that Mtb infection is not site-specific in correctional facility patients.
It is well known that patients with HIV have an increased risk of EPTB 13, 14 . Click et al. 12 found that HIV was associated with both exclusively EPTB and any EPTB. Moreover, the same study demonstrated that the association between individuals with HIV infection and extrapulmonary disease was greater for EPTB with concurrent pulmonary involvement than for exclusively EPTB alone. In our population, HIV was associated with EPTB with concurrent pulmonary involvement and any EPTB but not with exclusively EPTB. We further identified that HIV was associated with meningeal TB at more than five times the odds, while other sites were not found to be related. In addition, low CD4 lymphocyte counts in hospitalized patients with HIV-co-infected EPTB were found to be ESRD as a risk factor for EPTB has also been reported in studies in Taiwan and the US state of Georgia 17, 31 . Accordingly, ESRD was associated with exclusively EPTB, EPTB with concurrent pulmonary involvement, and all cases of EPTB compared to PTB in our population-based analysis. We also found that ESRD was specifically associated with pleural, lymphatic, bone and peritoneal TB. Thus, patients with ESRD are at a high risk of progressing to EPTB. One possibility regarding the underlying mechanisms is that the persistence of impaired cellmediated immunity in ESRD may leave these patients susceptible to Mtb infection or activation of latent infection 32 . This phenomenon has also been observed in organ transplantation receipts who receive post-transplant immunosuppressive medications that specifically target T cell-mediated immunity 33, 34 . In regard to the screening strategy among patients with chronic renal disease (CRD), both the American Thoracic Society 35 and American Transplant Society 36 guidelines recommend that all immunocompromised subjects and transplant candidates be screened for TB with a tuberculin skin test (TST) or IFN-γ releasing assay (IGRA). The WHO provides more specific guidance on screening all dialysis patients with TST or IGRAs 37 . Beyond the screening strategy, diagnosis of EPTB remains difficult because of the paucibacillary nature. Thus, it is necessary to advance knowledge about the association of CRD/ESRD and EPTB and strategies to improve the prevention, detection, and treatment of EPTB with ESRD.
Consistent with the current literature, our analyses showed that age ≥45 years, ESRD, HIV+ status, excessive alcohol use within the past 12 months, and abnormal chest radiography were significantly associated with mortality during anti-TB treatment in patients with exclusively EPTB 17, 38 . In the USA, excess alcohol use may represent a large portion of TB burden 38 . The relationship between excessive alcohol use and the development of TB disease as well as TB-associated morbidity and mortality has been presumed to be due to impaired immune function 39 . Other confounding factors such as older age, diabetes, ESRD, and HIV are all related to decreased immune function. HIV was highly associated with mortality during treatment in our analysis, which is consistent with other epidemiologic and observational studies with mortality ranging from 6% to 32% 40 . Another important finding of our study was that ESRD was associated with more than quadruple the odds of mortality during anti-TB treatment in patients having exclusively EPTB. Given these findings, we suggest that patients with decreased immune function or immunosuppression are at an increased risk of mortality during treatment and that host immune response may determine the difference in survival. Approaches to meet the objective of optimizing efficacy and safety of treatment, especially for TB-HIV coinfection as well as ESRD, to reduce mortality both in adults and children are urgently required. As shown in a prospective cohort study that enrolled hospitalized HIV co-infected patients with microbiologically confirmed drug-susceptible TB in South Africa, mortality within 12 weeks was positively associated with elevated concentrations of procalcitonin, activation of the innate immune system, and anti-inflammatory markers 41 . Procalcitonin, a product induced by TNF-α and IL-2 during a bacterial infection, has already shown its value in distinguishing TB from bacterial pneumonia and TB meningitis from bacterial meningitis 42, 43 . A higher level of serum procalcitonin was associated with a poorer prognosis in TB meningitis 43 . Moreover, serum procalcitonin has been reported as an appropriate indicator of infection in ESRD patients 44 . Therefore, identifying a correlation between the host's immunologic phenotypes and the severity of disease or comorbidities, as well as treatment response, would enable the direct selection of host-directed therapeutics and a potentially beneficial and improved TB outcome.
Another important consideration for the risk of EPTB is diabetes status, as several studies have identified diabetes as a risk factor for developing active TB and poor treatment outcomes 45 . For instance, a study in the UK has reported that patients with diabetes had an increased risk of developing TB compared to a control group 46 . Among patients undergoing TB treatment, patients with diabetes had an increased mortality risk compared to those without diabetes 47 . However, compared to the control group, TB patients with diabetes had an increased probability of having PTB as opposed to EPTB 46 . Furthermore, both our study and a cohort study in the US state of Georgia found TB patients with diabetes to have an increased probability of EPTB as opposed to PTB, and diabetes was not associated with EPTB mortality during TB treatment 17 . In an additional study, diabetes did not contribute to TB-related death in adult patients in the USA 48 . Thus, the inconsistent findings encourage further investigations on the impact of diabetes in PTB and EPTB patients. It is worth emphasizing that the incidence of ESRD is higher in the diabetic population than in the non-diabetic population 49 . Since ESRD is an independent risk factor for EPTB as shown in our study, it may be necessary to account for the association between diabetes and ESRD as a co-epidemic, which would potentially account for the risk of EPTB as well as treatment outcomes.
Among available data for patients with exclusively EPTB, the most prevalent Mtb lineages were EuroAmerican L4, followed by East Asian L2 and IndoOceanic L1. This finding was consistent with a previous nationwide study in the USA 12 . Click et al. 12 suggested that the percentage of cases with exclusively EPTB differs for the four lineages-East Asian, 13.0%; Euro-American, 13.8%; Indo-Oceanic, 22.6%; and East African-Indian, 34.3%-while EPTB with pulmonary involvement did not. However, Click's study did not show data for M. bovis. Consistent with the results of previous studies 50 , 51 , we found a higher proportion of M. bovis in patients with exclusively EPTB than in patients with exclusively PTB or EPTB with pulmonary involvement. Geographically, patients with M. bovis TB residing along the US-Mexico border had a disproportionately high incidence of M. bovis 50 . This may also be reflected in our results, as Texas is a US state bordering Mexico. The tradition of raw milk and cheese consumption, especially in Hispanic communities, may be another common reason for M. bovis infection 52 . Additionally, we found that positive smear and culture, direct susceptibility test profile and genotyping lineage were not risk factors for mortality from exclusively EPTB during TB treatment. These results may be limited due to many individuals with unknown Mtb status, either because the test was not performed or because the results were not recorded. Instead of bacterial factors, host risk factors such as HIV, age ≥45, excessive alcohol use, and abnormal chest X-ray findings were associated with mortality during treatment of EPTB in our study.
One important limitation of our study is the unavailability of data in some categories. Therefore, the reported crude and adjusted odds ratios could be biased due to unmeasured covariates or unknown confounders. State TB surveillance reporting does not include the depth of clinical information necessary to further investigate recognized risk factors in the epidemiology of EPTB (e.g., CD4 lymphocyte counts for HIV patients and smoking status). An observational design in a large cohort will be necessary to assess the true effect of these factors. Given that Texas has one of the highest TB prevalence rates of any US state and has a more diverse population than many other states, findings from our analysis may not apply to settings elsewhere in the country.
Conclusion
The present study characterized the important differences in the population-level dynamics of EPTB, as well as its specific sites, which included demographic factors and clinical characteristics in addition to the heterogeneities within sites of EPTB during the 7-year study period. Age ≥45 years, HIV+ status, and ESRD were identified as risk factors for both EPTB establishment and resulting mortality during treatment. Although the scientific question of the extrapulmonary dissemination remains to be answered, the study's findings could allow us to design supportive treatments for specific subgroups of patients with increased mortality, such as those with a HIV+ status and those with compromised renal function, in order to improve their outcomes and ultimately minimize the transmission of TB.
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